Skip to main content

Table 3 Calcium and active vitamin D supplementation following total parathyroidectomy

From: Risk factors and clinical course of hungry bone syndrome after total parathyroidectomy in dialysis patients with secondary hyperparathyroidism

 

No preoperative use of active vitamin D

Preoperative use of active vitamin D

p value

a. Average daily dose of active vitamin Da supplementation (μg)

 Postop Day 14

2.33 ± 1.74

2.18 ± 1.50

0.729

 Postop Month 1

2.19 ± 1.68

2.12 ± 1.47

0.876

 Postop Month 3

1.73 ± 1.56

1.61 ± 1.34

0.760

 Postop Year 1

1.20 ± 1.71

0.91 ± 1.00

0.416

Average daily dose of elemental calciumb supplementation (mg)

 Postop Day 14

6070.3 ± 4588.2

4562.7 ± 3790.0

0.179

 Postop Month 1

5760.1 ± 4607.1

4543.5 ± 3790.4

0.289

 Postop Month 3

4455.6 ± 4040.3

3280.5 ± 3624.0

0.255

 Postop Year 1

2635.2 ± 2591.4

2328.4 ± 3733.1

0.713

 

No preoperative use of cinacalcet

Preoperative use of cinacalcet

 

b. Average daily dose of active vitamin Da supplementation (μg)

 Postop Day 14

2.14 ± 1.61

2.73 ± 1.74

0.238

 Postop Month 1

2.03 ± 1.55

2.64 ± 1.69

0.211

 Postop Month 3

1.58 ± 1.43

2.03 ± 1.62

0.320

 Postop Year 1

0.96 ± 1.11

1.64 ± 2.54

0.387

Average daily dose of elemental calciumb supplementation (mg)

 Postop Day 14

5421.4 ± 4243.3

5818.4 ± 4424.1

0.761

 Postop Month 1

5180.7 ± 4263.0

5748.0 ± 4693.8

0.670

 Postop Month 3

3864.0 ± 3413.5

4553.7 ± 5381.1

0.565

 Postop Year 1

2270.6 ± 1909.5

3551.9 ± 5541.6

0.446

  1. aCalcitriol or alfacalcidol
  2. bIn the form of oral calcium carbonate tablets (40% elemental calcium)